
Zucodap 10mg Tablet
Marketer
Zuciya Lifesciences
Salt Composition
Dapagliflozin (10mg)
Overview Zucodap 10mg Tablet
Dapagliflozin 10mg tablets are prescribed, either independently or alongside other medications, for managing type 2 diabetes. They effectively regulate elevated blood glucose, thereby lessening the probability of severe diabetic complications and contributing to heart disease prevention. This medication may be ingested with or without food, at any convenient time, but consistent daily timing is recommended. Dosage is determined by your physician; cessation requires medical consultation, as abrupt discontinuation can elevate blood sugar, potentially leading to severe complications such as renal impairment or vision loss. This drug forms part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common adverse effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Dehydration is a possibility; increased fluid intake is advised. Practicing good hygiene helps minimize genital fungal infections. Prior to initiating treatment, disclose any existing kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before commencing this medication. Limit alcohol consumption, as it may heighten the risk of certain side effects. Regular blood glucose monitoring is crucial while using this medicine.
Uses of Zucodap 10mg Tablet
Managing type 2 diabetes
Major Benefits of Zucodap 10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 10mg Zucodap tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key – take it at the same time each day.
Common Side effects of Zucodap 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Zucodap 10mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 10mg Zucodap tablet whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.
How Zucodap 10mg Tablet works:
Glucodex 10mg tablets are used to manage diabetes. They function by facilitating the excretion of surplus glucose via the urinary tract.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zucodap 10mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Zucodap 10mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Zucodap 10mg Tablets are likely incompatible. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Zucodap 10mg Tablets due to potential safety concerns. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
Individuals with hepatic impairment may safely utilize Zucodap 10mg tablets without requiring a modified dosage.
What if you forget to take Zucodap 10mg Tablet :
Should you forget a Zucodap 10mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Zucodap 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
